Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q96F07

Entry ID Method Resolution Chain Position Source
AF-Q96F07-F1 Predicted AlphaFoldDB

595 variants for Q96F07

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000656389
VAR_080817
RCV001174530
RCV001266302
rs1131692231
RCV001856988
CA361965782
87 R>C Developmental and epileptic encephalopathy, 65 Variant assessed as Somatic; impact. Inborn genetic diseases DEE65 [ClinVar, NCI-TCGA, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
NCI-TCGA
dbSNP
RCV000656388
VAR_080818
rs1554108163
CA361965785
87 R>L Developmental and epileptic encephalopathy, 65 DEE65 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs1554108163
VAR_080819
CA361965784
RCV000656390
RCV001384044
87 R>P Developmental and epileptic encephalopathy, 65 DEE65 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs1131692231
CA361965780
RCV000987625
87 R>S Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA3533525
RCV001266446
rs771368440
RCV002541626
358 R>H Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001250402
rs1760440801
455 A>P Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
RCV000995753
CA361968887
rs971284726
468 E>D Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA130173886
rs868243549
RCV001329522
514 R>* Developmental and epileptic encephalopathy, 65 Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
Ensembl
NCI-TCGA
dbSNP
RCV001879764
rs1663188420
RCV001249779
587 R>W CYFIP2-related neurodevelopmental disorders [ClinVar] Yes ClinVar
dbSNP
RCV001329523
rs1760952349
637 Q>K Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
rs369858004
RCV001250400
664 I>M Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
RCV001261365
rs1760957806
RCV001250401
665 E>K Developmental and epileptic encephalopathy, 65 Intellectual disability [ClinVar] Yes ClinVar
dbSNP
rs1761007330
RCV001329524
696 N>D Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
rs1761011834
RCV001527669
RCV001268518
714 E>G Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
RCV001027702
rs1581069148
CA361970696
724 D>G Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001250403
rs1581069143
724 D>H Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
CA361970693
RCV001027670
rs1581069143
724 D>Y Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1761161860
RCV001250399
725 Q>R Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
RCV001880149
CA3533829
RCV001267558
rs373467559
808 I>T Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001871883
rs934692505
RCV001336182
CA130181537
819 I>T Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001329525
rs1762073906
878 N>S Developmental and epileptic encephalopathy, 65 [ClinVar] Yes ClinVar
dbSNP
RCV001266821
rs1767447649
1231 R>W Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
rs1241752177
CA361965011
3 T>M No ClinGen
TOPMed
gnomAD
CA361965026
rs1421838253
5 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1171593312
CA361965082
10 A>S No ClinGen
gnomAD
CA361965112
rs1359793519
13 N>D No ClinGen
gnomAD
CA361965138
rs1580971770
15 D>A No ClinGen
Ensembl
TCGA novel 22 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361965216
rs1580971838
22 L>P No ClinGen
Ensembl
TCGA novel 29 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361965309
rs1206182927
30 E>K No ClinGen
gnomAD
rs1461152506
CA361965322
31 P>A No ClinGen
gnomAD
rs1461152506
CA361965325
31 P>S No ClinGen
gnomAD
CA361965374
rs1186118351
36 I>V No ClinGen
gnomAD
rs369640959
CA130143628
37 M>I No ClinGen
ESP
TOPMed
gnomAD
rs1364445744
CA361965391
37 M>T No ClinGen
TOPMed
CA130143621
rs371710290
37 M>V No ClinGen
ESP
TOPMed
gnomAD
CA3533273
rs756226998
43 D>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 47 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361965498
rs1335366357
49 R>K No ClinGen
TOPMed
rs1465794047
CA361965616
66 H>R No ClinGen
TOPMed
rs1580994172
CA361965680
72 M>I No ClinGen
Ensembl
rs1462491993
CA361965688
74 E>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1241385487
CA361965699
75 E>A No ClinGen
TOPMed
CA361965712
rs1201497625
77 H>Y No ClinGen
gnomAD
CA3533305
rs373074465
78 E>G No ClinGen
ESP
ExAC
gnomAD
CA361965733
rs1317603023
80 A>T No ClinGen
TOPMed
rs866878368
CA130151060
80 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1474759625
CA361965747
82 M>T No ClinGen
gnomAD
rs759428926
CA3533307
82 M>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 83 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1561699191 95 Q>P No Ensembl
rs1580994394
CA361965833
95 Q>P No ClinGen
Ensembl
TCGA novel 98 C>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533339
rs753263281
100 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1049065748
CA130152204
103 N>D No ClinGen
Ensembl
TCGA novel 104 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361965936
rs1392531290
108 Y>S No ClinGen
gnomAD
CA130152220
rs772047793
109 E>A No ClinGen
Ensembl
rs763631624
CA3533341
117 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs763631624
CA361965997
117 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3533340
rs750559695
117 P>S No ClinGen
ExAC
gnomAD
CA3533344
rs778708640
121 K>E No ClinGen
ExAC
gnomAD
rs1231011270
CA361966041
124 K>Q No ClinGen
gnomAD
rs758280534
CA3533346
126 M>T No ClinGen
ExAC
gnomAD
rs1422784359
CA361966168
130 R>C No ClinGen
gnomAD
TCGA novel 130 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764792377
CA3533362
132 A>V No ClinGen
ExAC
gnomAD
rs1256818259
CA361966208
133 I>T No ClinGen
gnomAD
rs1357183737
CA361966230
135 R>Q No ClinGen
gnomAD
CA361966229
rs1443507484
135 R>W No ClinGen
TOPMed
CA361966267
rs1280157801
138 S>N No ClinGen
TOPMed
rs1377123656
CA361966274
139 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA361966294
rs1581008322
140 V>G No ClinGen
Ensembl
rs780027307
CA3533365
140 V>M No ClinGen
ExAC
gnomAD
rs1225854186
CA361966328
144 C>G No ClinGen
gnomAD
rs865866918
CA130155165
146 A>V No ClinGen
Ensembl
CA130155195
rs779775850
147 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA361966405
rs1442196439
150 K>R No ClinGen
gnomAD
CA3533369
rs749327820
165 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA3533370
rs369872275
166 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3533371
rs528604984
167 M>L No ClinGen
1000Genomes
ExAC
gnomAD
CA130155259
rs528604984
167 M>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1178497713
CA361966644
171 L>Q No ClinGen
gnomAD
CA361966712
rs1422812751
176 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA361966772
rs1397718630
181 V>I No ClinGen
gnomAD
rs769152996
CA3533376
188 Y>C No ClinGen
ExAC
gnomAD
CA361966857
rs1205125891
191 A>T No ClinGen
gnomAD
CA361966861
rs1234450031
191 A>V No ClinGen
gnomAD
rs1385431468
CA361966877
194 F>I No ClinGen
gnomAD
CA361966891
rs1256720359
196 R>W No ClinGen
gnomAD
rs1411083790
CA361966928
201 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1331446131
CA361966943
203 S>Y No ClinGen
gnomAD
rs267600513
CA130161306
207 S>L No ClinGen
Ensembl
TCGA novel 213 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 213 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 214 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533420
rs767171110
223 C>G No ClinGen
ExAC
gnomAD
CA361967165
rs267600514
233 G>R No ClinGen
gnomAD
CA130162420
rs267600514
233 G>S No ClinGen
gnomAD
CA130162423
rs955653146
241 I>V No ClinGen
TOPMed
rs779088823
CA130162445
250 E>K No ClinGen
Ensembl
CA361967297
rs1363710900
251 N>S No ClinGen
gnomAD
CA361967305
rs1296466462
252 K>M No ClinGen
gnomAD
rs1561708197
CA361967308
253 M>V No ClinGen
Ensembl
rs1399394532
CA361967320
254 Y>F No ClinGen
gnomAD
rs751739881
CA3533427
254 Y>H No ClinGen
ExAC
gnomAD
rs1302467306
CA361967336
257 P>A No ClinGen
gnomAD
CA3533429
rs781345564
258 S>N No ClinGen
ExAC
gnomAD
TCGA novel 262 M>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533430
rs748543983
262 M>T No ClinGen
ExAC
gnomAD
rs1167049602
CA361967422
267 M>L No ClinGen
gnomAD
TCGA novel 267 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1483212474
CA361967503
278 V>A No ClinGen
TOPMed
CA361967499
rs1292812959
278 V>I No ClinGen
gnomAD
rs1448668025
CA361967529
282 Y>H No ClinGen
gnomAD
CA361967545
rs1425190532
284 L>V No ClinGen
TOPMed
gnomAD
CA3533460
rs761673467
286 A>T No ClinGen
ExAC
rs1581024840
CA361967566
287 K>R No ClinGen
Ensembl
CA130165162
rs974921667
294 K>R No ClinGen
TOPMed
CA361967624
rs1375758390
295 I>T No ClinGen
gnomAD
CA361967632
rs1156399205
296 D>G No ClinGen
TOPMed
gnomAD
rs866532867
CA130165169
297 K>Q No ClinGen
Ensembl
TCGA novel 297 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361967664
rs1314336556
300 K>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1482979029
CA361967681
301 Q>* No ClinGen
gnomAD
CA361967704
rs1422678427
304 V>A No ClinGen
gnomAD
CA361967700
rs1168431281
304 V>M No ClinGen
gnomAD
rs1414761449
CA361967710
305 V>A No ClinGen
gnomAD
rs1177834153
CA361967715
306 P>H No ClinGen
gnomAD
CA130166364
rs940976354
308 F>Y No ClinGen
Ensembl
rs1444797400
CA361967782
316 A>S No ClinGen
TOPMed
rs1341817209
CA361967789
317 R>G No ClinGen
gnomAD
rs769628287
CA3533479
319 I>V No ClinGen
ExAC
gnomAD
rs3207362
CA130166389
320 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
VAR_030953
CA130166388
rs3207362
320 K>E RNA edited version [UniProt] No ClinGen
UniProt
Ensembl
dbSNP
rs1278048851
CA361967824
322 S>N No ClinGen
gnomAD
rs766783609
CA130166410
323 A>T No ClinGen
Ensembl
rs1221242924
CA361967837
324 H>P No ClinGen
TOPMed
gnomAD
CA361967838
rs1221242924
324 H>R No ClinGen
TOPMed
gnomAD
rs773104584
CA3533480
328 N>S No ClinGen
ExAC
gnomAD
rs533976899
CA3533481
329 K>E No ClinGen
1000Genomes
ExAC
gnomAD
CA361967882
rs1216768680
330 S>P No ClinGen
gnomAD
CA3533482
rs772144956
331 K>R No ClinGen
ExAC
gnomAD
rs148350606
CA3533517
333 T>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA361967940
TCGA novel
rs1374314708
336 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
TOPMed
TCGA novel 337 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780920901
CA3533519
338 S>T No ClinGen
ExAC
TOPMed
gnomAD
CA361967975
rs1438922382
341 P>R No ClinGen
TOPMed
CA3533521
rs748322670
342 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 342 Q>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361967993
rs1478475027
344 N>D No ClinGen
gnomAD
rs548540530
CA3533523
349 M>T No ClinGen
1000Genomes
ExAC
gnomAD
CA361968032
rs1465390767
349 M>V No ClinGen
gnomAD
CA361968048
rs1404679458
351 Q>P No ClinGen
gnomAD
CA130167668
rs990110659
353 R>Q No ClinGen
TOPMed
gnomAD
rs1473601392
CA361968071
354 D>E No ClinGen
gnomAD
rs763206176
CA361968096
358 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA3533524
rs763206176
358 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA3533526
rs568356129
359 F>Y No ClinGen
1000Genomes
ExAC
gnomAD
CA3533527
rs760060931
360 I>V No ClinGen
ExAC
gnomAD
CA361968128
rs1256350092
363 L>F No ClinGen
gnomAD
rs760249068
CA3533530
364 A>S No ClinGen
ExAC
gnomAD
rs760249068
CA361968132
364 A>T No ClinGen
ExAC
gnomAD
CA361968139
rs1478185896
365 R>C No ClinGen
TOPMed
CA361968140
rs1245707971
365 R>H No ClinGen
TOPMed
rs1279004616
CA361968152
367 S>G No ClinGen
gnomAD
rs772567936
CA3533546
373 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs772567936
CA361968211
373 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs1453047125
CA361968235
378 D>N No ClinGen
gnomAD
rs965601006
CA130169867
380 Q>E No ClinGen
Ensembl
CA3533550
rs368645883
383 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3533548
rs760152670
383 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA361968282
rs1581039353
384 E>G No ClinGen
Ensembl
rs1486007509
CA361968278
384 E>K No ClinGen
TOPMed
rs781678629
CA3533552
385 E>G No ClinGen
ExAC
gnomAD
rs750246368
CA3533553
387 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA3533554
rs758334790
387 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs750246368
CA361968301
387 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs267600515
CA130169897
388 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs267600515
CA3533556
388 E>Q No ClinGen
ExAC
gnomAD
CA3533558
rs777932320
391 D>N No ClinGen
ExAC
gnomAD
rs749414939
CA3533559
394 L>V No ClinGen
ExAC
gnomAD
RCV001091685
CA361968349
rs1459314371
395 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA361968348
rs1239141371
395 R>W No ClinGen
gnomAD
rs745821702
CA3533560
396 G>C No ClinGen
ExAC
gnomAD
rs779176531
CA3533561
398 Q>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 400 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs775941668
CA3533564
405 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1459779106
RCV001310881
406 H>Q No ClinVar
dbSNP
CA361968420
rs1474295904
406 H>R No ClinGen
gnomAD
CA3533565
rs747579286
407 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs528137322
CA3533566
408 M>L No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 415 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1433894737
CA361968518
418 P>L No ClinGen
TOPMed
rs1279320547
CA361968577
426 D>A No ClinGen
gnomAD
TCGA novel 426 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs779089894
CA3533578
430 T>I No ClinGen
ExAC
gnomAD
rs1470256053
CA361968607
431 A>T No ClinGen
TOPMed
rs758726132
CA3533580
431 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs777072724
CA3533584
438 T>I No ClinGen
ExAC
gnomAD
CA361968664
rs1476300276
439 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1478749882
CA361968697
443 T>I No ClinGen
TOPMed
gnomAD
rs1194250877
CA361968722
447 K>Q No ClinGen
TOPMed
CA361968752
rs1418524864
451 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs770700428
CA3533606
461 Q>H No ClinGen
ExAC
gnomAD
CA361968836
rs1337604840
461 Q>R No ClinGen
TOPMed
rs1311634660
CA361968854
464 M>T No ClinGen
gnomAD
CA361968852
rs1447791798
464 M>V No ClinGen
gnomAD
rs1332632467
CA361968866
466 R>G No ClinGen
TOPMed
CA130173386
rs866027154
468 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs759348805
CA3533608
470 V>I No ClinGen
ExAC
gnomAD
CA361968914
rs1406302424
472 N>S No ClinGen
TOPMed
rs1034338489
CA130173403
480 Y>F No ClinGen
TOPMed
TCGA novel 481 A>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771799085
CA3533609
481 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs747636391
CA3533610
481 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 482 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1239470942
CA361969015
487 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1158518688
CA361969031
489 V>E No ClinGen
gnomAD
CA3533614
rs763089939
489 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA361969037
rs1478391225
490 T>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs755329609
CA3533617
492 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA130173424
rs370137201
494 P>S No ClinGen
ESP
TOPMed
CA3533618
rs781431530
496 R>Q Variant assessed as Somatic; 4.64e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs753188984
CA3533619
498 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA361969089
rs1581051078
499 V>G No ClinGen
Ensembl
rs1333538280
CA361969085
499 V>I No ClinGen
gnomAD
rs1334093854
CA361969092
500 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1352949437
CA361969108
502 K>R No ClinGen
TOPMed
CA3533622
rs748790899
503 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs372630008
CA3533643
509 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1229887836
CA361969203
515 K>Q No ClinGen
TOPMed
gnomAD
rs895353962
CA130173901
517 I>V No ClinGen
TOPMed
TCGA novel 518 C>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361969256
rs1427383890
522 G>R No ClinGen
gnomAD
rs746795054
CA3533646
524 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs768490332
CA3533647
526 P>L No ClinGen
ExAC
gnomAD
CA130173923
rs866280463
527 P>S No ClinGen
Ensembl
rs1374827540
CA361969292
528 N>S No ClinGen
gnomAD
TCGA novel 535 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1320119714
CA361969350
536 K>R No ClinGen
gnomAD
CA3533649
rs748115365
543 D>G No ClinGen
ExAC
gnomAD
CA361969397
rs1275022534
543 D>H No ClinGen
gnomAD
rs770984179
CA3533650
545 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1278958471
CA361969417
546 V>M No ClinGen
gnomAD
rs1260104340
CA361969430
548 R>Q No ClinGen
gnomAD
rs1043836870
CA130173941
548 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA361969483
rs1397162142
557 Q>K No ClinGen
gnomAD
CA361969545
rs1193169001
563 P>L No ClinGen
TOPMed
gnomAD
rs1420905117
CA361969565
566 L>F No ClinGen
gnomAD
CA361969577
rs1581057838
568 H>P No ClinGen
Ensembl
rs1452936034
CA361969604
572 G>V No ClinGen
gnomAD
CA361969607
rs1252924350
573 T>A No ClinGen
TOPMed
rs746704977
CA3533663
574 Q>L No ClinGen
ExAC
gnomAD
rs1196461908
CA361969622
575 G>D No ClinGen
TOPMed
CA130175106
rs935305186
576 R>* No ClinGen
TOPMed
gnomAD
rs368825709
CA130175111
576 R>Q No ClinGen
TOPMed
gnomAD
rs754728174
CA3533664
577 R>G No ClinGen
ExAC
gnomAD
CA361969629
rs1295694978
577 R>K No ClinGen
gnomAD
CA3533665
rs780977916
578 G>V No ClinGen
ExAC
gnomAD
CA361969646
rs1581057989
579 C>W No ClinGen
Ensembl
rs748051190
CA3533666
580 R>* No ClinGen
ExAC
TOPMed
gnomAD
CA361969649
rs988082033
580 R>L No ClinGen
gnomAD
rs988082033
CA130175129
580 R>Q No ClinGen
gnomAD
rs1581058022
CA361969655
581 S>F No ClinGen
Ensembl
rs1275445705
CA361969660
582 L>P No ClinGen
gnomAD
rs1246158458
CA361969657
582 L>V No ClinGen
gnomAD
CA130175606
rs865828464
583 L>M No ClinGen
Ensembl
CA361969685
rs1211552023
585 M>L No ClinGen
gnomAD
CA361969702
rs1484638367
587 R>Q No ClinGen
gnomAD
CA361969710
rs1561727470
588 T>N No ClinGen
Ensembl
TCGA novel 591 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1429933378
CA361969759
596 D>N No ClinGen
gnomAD
rs1372022291
CA361969784
599 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 605 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533675
rs370992962
607 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs765652619
CA3533677
609 D>E No ClinGen
ExAC
gnomAD
CA3533680
rs757817918
612 I>N No ClinGen
ExAC
TOPMed
gnomAD
CA3533679
rs757817918
612 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA361969892
rs1295078317
616 I>V No ClinGen
TOPMed
gnomAD
CA3533683
rs778090546
617 E>D No ClinGen
ExAC
gnomAD
CA361969911
rs1267012960
618 D>E No ClinGen
gnomAD
rs1199949263
CA361969923
620 H>Y No ClinGen
TOPMed
CA361969930
rs1236656663
621 K>E No ClinGen
gnomAD
rs1278268986
CA361969934
621 K>R No ClinGen
gnomAD
CA361969946
rs1209989067
623 S>A No ClinGen
gnomAD
CA361969966
rs1184436577
625 F>L No ClinGen
gnomAD
rs1482284867
CA361969982
628 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1399453268
CA361970066
638 Q>R No ClinGen
gnomAD
CA130176560
CA361970092
rs767132778
641 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1463225001
CA361970093
642 L>F No ClinGen
gnomAD
TCGA novel 644 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1281329663
CA361970115
645 L>F No ClinGen
gnomAD
CA3533705
rs753656201
645 L>P No ClinGen
ExAC
gnomAD
CA361970154
rs1342557086
650 F>L No ClinGen
TOPMed
rs1335168529
CA361970194
656 M>R No ClinGen
gnomAD
CA3533707
rs779064849
658 R>Q No ClinGen
ExAC
gnomAD
rs1467738313
CA361970211
659 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA361970256
rs1469059236
665 E>D No ClinGen
gnomAD
TCGA novel 669 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1255540251
CA361970298
671 I>V No ClinGen
Ensembl
rs748435704
CA3533711
673 T>M No ClinGen
ExAC
gnomAD
rs1331047842
CA361970370
681 E>D No ClinGen
gnomAD
TCGA novel 682 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 685 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361970457
rs1280400313
692 L>V No ClinGen
gnomAD
CA361970487
rs199725246
696 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3533734
rs749628390
696 N>S No ClinGen
ExAC
gnomAD
CA3533736
rs774796737
697 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA361970505
rs566311656
699 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3533738
rs566311656
699 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1484965602
CA361970513
700 Y>C No ClinGen
TOPMed
rs1174417313
CA361970522
701 Y>C No ClinGen
gnomAD
CA361970525
rs999593337
702 A>S No ClinGen
TOPMed
CA130177015
rs999593337
702 A>T No ClinGen
TOPMed
rs760173046
CA3533740
703 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1249206368
CA361970541
705 K>E No ClinGen
TOPMed
rs1171630496
CA361970557
707 K>E No ClinGen
gnomAD
rs11551374
CA130177047
712 Y>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1324383497
CA361970602
713 D>N No ClinGen
gnomAD
CA361970622
rs1292109821
715 I>M No ClinGen
TOPMed
rs1334962669
CA361970618
715 I>V No ClinGen
TOPMed
rs1443924850
CA361970661
719 V>A No ClinGen
TOPMed
CA3533764
rs577801159
734 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3533765
rs751489126
735 F>V No ClinGen
ExAC
gnomAD
rs760767488
CA3533766
740 A>G No ClinGen
ExAC
gnomAD
CA3533767
rs764101175
741 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs750788982
CA3533768
743 G>S No ClinGen
ExAC
gnomAD
CA3533781
rs762775564
745 V>A No ClinGen
ExAC
gnomAD
rs764091827
CA3533785
748 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA3533784
rs759402047
748 D>N No ClinGen
ExAC
gnomAD
rs535692197
CA3533786
750 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1415929389
CA361970884
750 R>H No ClinGen
TOPMed
gnomAD
CA361970896
rs1353891660
752 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3533788
rs765425949
752 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1205752398
CA361970949
759 G>V No ClinGen
TOPMed
rs1341378145
CA361970951
760 V>I No ClinGen
TOPMed
gnomAD
rs752048205
CA3533792
761 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1211441355
CA361970958
761 I>V No ClinGen
gnomAD
CA130179960
rs367713994
763 P>L No ClinGen
ESP
TOPMed
CA3533795
rs747638094
764 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs781781815
CA3533794
764 Y>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 765 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769467382
CA3533796
766 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA3533798
rs748914944
768 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA3533799
rs770698075
769 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs376060688
CA3533800
769 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA130179989
rs1024659556
771 E>A No ClinGen
gnomAD
rs980392146
CA130180004
779 V>I No ClinGen
TOPMed
gnomAD
rs771896801
CA3533822
786 I>T No ClinGen
ExAC
rs549089526
CA3533821
786 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1267140890
CA361971145
788 L>F No ClinGen
gnomAD
CA130181495
rs896876354
790 R>S No ClinGen
TOPMed
gnomAD
CA130181510
rs991288109
793 T>S No ClinGen
Ensembl
rs769807842
CA3533825
795 R>C No ClinGen
ExAC
gnomAD
rs17850790
CA130181519
796 I>T No ClinGen
Ensembl
TCGA novel 797 S>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361971212
rs1410666252
799 A>S No ClinGen
TOPMed
gnomAD
CA361971211
rs1410666252
799 A>T No ClinGen
TOPMed
gnomAD
rs1325126175
CA361971219
800 M>T No ClinGen
TOPMed
gnomAD
CA130181525
rs915714723
800 M>V No ClinGen
TOPMed
gnomAD
rs1365489154
CA361971224
801 Y>H No ClinGen
gnomAD
CA361971252
rs1418922914
804 L>F No ClinGen
TOPMed
gnomAD
rs1463208745
CA361971267
806 Q>H No ClinGen
gnomAD
CA130181530
rs947342930
807 A>S No ClinGen
gnomAD
TCGA novel 807 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533828
rs139353471
808 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA361971290
rs1435701430
810 R>H No ClinGen
gnomAD
rs1210382953
CA361971313
813 S>T No ClinGen
TOPMed
rs772497690
CA3533849
822 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA3533852
rs764483940
826 L>R No ClinGen
ExAC
rs201559066
CA3533851
826 L>V No ClinGen
ExAC
gnomAD
TCGA novel 827 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754411459
CA3533853
827 E>G No ClinGen
ExAC
gnomAD
rs1486835023
CA361971998
828 I>S No ClinGen
gnomAD
CA361971994
rs1258680778
828 I>V No ClinGen
gnomAD
CA3533856
RCV001310882
rs750024153
830 R>Q No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs764829531
CA3533855
830 R>W No ClinGen
ExAC
gnomAD
CA3533857
rs758052022
832 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs374132627
CA3533860
833 H>R No ClinGen
ESP
ExAC
gnomAD
rs780950093
CA3533861
834 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA3533863
rs770858656
834 R>Q No ClinGen
ExAC
gnomAD
rs780950093
CA3533862
834 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3533864
rs779054237
837 C>R No ClinGen
ExAC
gnomAD
CA361972047
rs1331935533
837 C>Y No ClinGen
gnomAD
TCGA novel 839 H>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3533865
rs534756048
839 H>R No ClinGen
1000Genomes
ExAC
gnomAD
CA3533866
rs377648376
840 M>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs763792787
CA3533867
841 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA361972085
rs1581094733
842 L>P No ClinGen
Ensembl
CA3533870
rs776958013
846 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA361972118
rs1347728182
847 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1413796917
CA361972130
848 M>I No ClinGen
TOPMed
gnomAD
TCGA novel 848 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA130141687
rs58005665
850 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA3533872
rs58005665
850 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs749930524
CA3533873
853 N>S No ClinGen
ExAC
CA361972176
rs1278354936
855 N>S No ClinGen
TOPMed
gnomAD
CA130141696
rs11551375
857 S>P No ClinGen
Ensembl
rs377031549
CA3533875
858 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3533876
rs751254864
862 R>C No ClinGen
ExAC
gnomAD
TCGA novel 868 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 869 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361972363
rs1401165380
881 Y>C No ClinGen
gnomAD
CA361972377
rs1400952041
882 N>S No ClinGen
gnomAD
TCGA novel 887 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 888 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs962853641
CA130142744
890 R>Q No ClinGen
Ensembl
rs867115883
CA130142728
890 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA3533908
rs371766099
892 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs773906215
CA3533910
896 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs375088064
CA3533911
899 P>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 901 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361972892
rs1162115179
903 K>N No ClinGen
gnomAD
TCGA novel 905 A>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 905 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA130142775
rs373799565
912 L>V No ClinGen
ESP
rs768136187
CA130142779
913 Y>H No ClinGen
Ensembl
rs1260711454
CA361976585
917 P>L No ClinGen
gnomAD
CA3534113
rs773991920
917 P>T No ClinGen
ExAC
gnomAD
CA361976607
rs1193289827
920 I>V No ClinGen
gnomAD
rs771916686
CA3534115
921 A>S No ClinGen
ExAC
gnomAD
CA361976627
rs1480245320
922 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA361976625
rs1480245320
922 Y>S No ClinGen
gnomAD
CA361976633
rs1414440150
923 S>N No ClinGen
gnomAD
CA361976651
rs1208018065
925 I>N No ClinGen
TOPMed
gnomAD
rs1325752383
CA361976649
925 I>V No ClinGen
TOPMed
rs780090044
CA130156821
928 S>F No ClinGen
Ensembl
CA130156831
rs954520587
929 Y>H No ClinGen
Ensembl
rs867293635
CA130156857
930 R>K No ClinGen
Ensembl
TCGA novel 932 F>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753859417
CA361976715
933 V>L No ClinGen
ExAC
gnomAD
CA3534119
rs753859417
933 V>M No ClinGen
ExAC
gnomAD
CA361976731
rs1343373167
935 P>S No ClinGen
gnomAD
CA361976742
rs1404072621
936 P>L No ClinGen
gnomAD
CA361976741
rs1177593362
936 P>S No ClinGen
TOPMed
TCGA novel 938 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs9313557
CA3534121
941 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1375048757
CA361976797
942 C>F No ClinGen
gnomAD
rs781455496
CA3534124
946 G>A No ClinGen
ExAC
gnomAD
rs770403640
CA3534129
960 I>T No ClinGen
ExAC
gnomAD
rs778281246
CA3534130
963 S>N No ClinGen
ExAC
gnomAD
rs778281246
CA3534131
963 S>T No ClinGen
ExAC
gnomAD
CA361977160
rs1407889712
966 Q>R No ClinGen
gnomAD
CA361977197
rs1349235758
969 I>V No ClinGen
TOPMed
rs1231557512
CA361977300
977 I>T No ClinGen
TOPMed
TCGA novel 978 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA130157521
rs867900382
981 P>H No ClinGen
Ensembl
rs1381279833
CA361977421
986 L>F No ClinGen
TOPMed
rs1337845533
CA361977435
988 R>* No ClinGen
TOPMed
TCGA novel 994 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1315592512
CA361977625
995 G>A No ClinGen
TOPMed
TCGA novel 995 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1159794405
CA361977628
996 I>V No ClinGen
gnomAD
rs769664920
CA3534175
1003 Q>* No ClinGen
ExAC
gnomAD
rs377125065
CA3534178
1011 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA361977793
rs1241280030
1015 T>I No ClinGen
gnomAD
CA130158377
rs996091939
1017 V>M No ClinGen
gnomAD
CA130158384
rs927671349
1023 E>A No ClinGen
TOPMed
rs1292365985
CA361977850
1024 V>M No ClinGen
gnomAD
rs762034251
CA3534183
1031 C>Y No ClinGen
ExAC
gnomAD
rs1581141802
CA361978026
1037 A>G No ClinGen
Ensembl
rs1402096503
CA361980694
1040 Q>R No ClinGen
TOPMed
CA361980749
rs1333721993
1044 C>G No ClinGen
TOPMed
CA3534231
rs753824205
1050 A>S No ClinGen
ExAC
gnomAD
rs753824205
CA3534230
1050 A>T No ClinGen
ExAC
gnomAD
rs760142049
CA3534232
1052 F>Y No ClinGen
ExAC
gnomAD
rs753510856
CA3534234
1055 I>V No ClinGen
ExAC
gnomAD
rs756987284
CA3534235
1061 I>M No ClinGen
ExAC
gnomAD
CA361980978
rs1382834588
1061 I>V No ClinGen
gnomAD
TCGA novel 1064 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3534251
rs763607353
1066 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs368529367
CA130177353
1066 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368529367
CA3534252
1066 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1275459874
CA361981120
1067 L>P No ClinGen
gnomAD
rs764928113
CA3534254
1070 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs371277463
CA3534255
1071 M>I No ClinGen
ESP
ExAC
gnomAD
rs374707103
CA3534256
1073 R>C No ClinGen
ESP
ExAC
gnomAD
rs1186884501
CA361981256
1078 Y>C No ClinGen
TOPMed
gnomAD
CA361981273
rs1421214095
1079 A>D No ClinGen
gnomAD
rs756207677
CA3534259
1080 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA3534263
rs779041559
1083 L>V No ClinGen
ExAC
gnomAD
rs780552029
CA3534266
1084 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA130177384
rs747475869
1087 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs769218609
CA3534268
1088 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA3534269
rs776107230
1089 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA361981385
rs1456995793
1089 R>W No ClinGen
TOPMed
CA130177396
rs866764350
1092 T>A No ClinGen
Ensembl
TCGA novel 1094 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769406851
CA361981437
1094 Q>P No ClinGen
ExAC
gnomAD
rs769406851
CA3534271
1094 Q>R No ClinGen
ExAC
gnomAD
CA130181476
rs747174438
1095 Q>E No ClinGen
Ensembl
rs764150455
CA3534316
1096 I>N No ClinGen
ExAC
gnomAD
rs763134967
CA3534318
1097 A>T No ClinGen
ExAC
gnomAD
CA3534319
rs766472184
1098 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1420701830
CA361981892
1099 A>T No ClinGen
TOPMed
CA130181487
rs868315333
1100 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3534321
rs755280890
1101 E>K No ClinGen
ExAC
gnomAD
rs1340812030
CA361981967
1106 T>S No ClinGen
gnomAD
CA361981997
rs1581210153
1111 C>G No ClinGen
Ensembl
rs753130386
CA3534323
1113 G>V No ClinGen
ExAC
gnomAD
rs1205335914
CA361982027
1116 M>V No ClinGen
gnomAD
CA361982036
rs1225594310
1117 F>I No ClinGen
TOPMed
gnomAD
TCGA novel 1118 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3534325
rs778379924
1118 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 1119 V>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361982056
rs1581210202
1119 V>G No ClinGen
Ensembl
CA361982072
rs1176749642
1122 T>N No ClinGen
gnomAD
CA361982077
rs1237477468
1123 R>G No ClinGen
gnomAD
rs748704223
CA3534326
1123 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 1124 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs756811832
CA3534327
1124 I>V No ClinGen
ExAC
gnomAD
rs745519217
CA3534329
1125 R>Q No ClinGen
ExAC
gnomAD
CA3534328
rs778648138
1125 R>W No ClinGen
ExAC
gnomAD
CA361982130
rs1401899928
1131 P>R No ClinGen
gnomAD
CA361982132
rs1463586912
1132 I>L No ClinGen
gnomAD
rs200428535
CA3534332
1134 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3534331
rs775411830
1134 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3534333
rs374666951
1135 G>A No ClinGen
ESP
ExAC
gnomAD
rs776663646
CA3534334
1136 P>S No ClinGen
ExAC
gnomAD
rs771013880
CA3534336
1137 P>L No ClinGen
ExAC
gnomAD
CA3534335
rs562843766
1137 P>S No ClinGen
ExAC
gnomAD
CA361982181
rs1446711858
1140 N>S No ClinGen
TOPMed
rs764457342
CA3534342
1142 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3534344
rs756653541
1143 M>I No ClinGen
ExAC
gnomAD
CA361982210
rs1472327478
1144 H>Q No ClinGen
TOPMed
gnomAD
TCGA novel 1145 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3534345
rs577190281
1145 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs758101660
CA3534347
1146 D>N No ClinGen
ExAC
gnomAD
rs758101660
CA130181559
1146 D>Y No ClinGen
ExAC
gnomAD
rs779892555
CA3534348
1148 C>R No ClinGen
ExAC
gnomAD
TCGA novel 1151 F>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768520032
CA3534351
1153 R>L No ClinGen
ExAC
gnomAD
rs768520032
CA3534350
1153 R>Q No ClinGen
ExAC
gnomAD
CA3534349
rs376484231
1153 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 1154 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs199945789
CA3534353
1155 W>G No ClinGen
ExAC
gnomAD
rs201475685
CA130181591
1156 S>G No ClinGen
gnomAD
rs369611074
CA3534355
1157 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA3534356
rs772237862
1160 F>C No ClinGen
ExAC
gnomAD
CA361982319
rs1345675109
1161 V>M No ClinGen
TOPMed
gnomAD
CA3534359
rs148677157
1163 C>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA361982359
rs1217061527
1167 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1206531195
CA361982394
1171 F>L No ClinGen
TOPMed
CA361982639
rs1332750198
1176 C>Y No ClinGen
TOPMed
CA361982652
rs1399075744
1178 G>S No ClinGen
TOPMed
rs1457798273
CA361982677
1181 L>F No ClinGen
TOPMed
gnomAD
CA3534394
rs556174999
1189 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA361982756
rs1370434216
1190 V>D No ClinGen
gnomAD
TCGA novel 1192 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA130182387
CA130182384
rs865852628
1194 Q>H No ClinGen
Ensembl
rs757246607
CA3534396
1195 Q>E No ClinGen
ExAC
gnomAD
rs895624559
CA130182393
1196 R>C No ClinGen
TOPMed
gnomAD
rs780179999
CA3534397
1196 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs747100012
CA3534398
1197 R>C No ClinGen
ExAC
gnomAD
CA361982834
rs1445791014
1197 R>H No ClinGen
gnomAD
CA361982832
rs1445791014
1197 R>P No ClinGen
gnomAD
rs1313098894
CA361982863
1199 D>A No ClinGen
gnomAD
CA3534400
rs535422654
1200 L>P No ClinGen
1000Genomes
ExAC
gnomAD
rs1209059748
CA361982892
1202 D>N No ClinGen
TOPMed
rs1201414786
CA361982965
1207 L>M No ClinGen
TOPMed
gnomAD
rs867787148
CA130182440
1210 V>L No ClinGen
Ensembl
TCGA novel 1211 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361983015
rs1581213968
1211 Q>R No ClinGen
Ensembl
CA361983070
rs1424598314
1215 G>R No ClinGen
gnomAD
rs1478843898
CA361983139
1219 I>T No ClinGen
gnomAD
rs1379295281
CA361983308
1224 P>A No ClinGen
gnomAD
rs770197583
CA3534420
1228 M>I No ClinGen
ExAC
gnomAD
CA3534422
rs749706783
1230 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3534423
rs771443874
1231 R>Q No ClinGen
ExAC
gnomAD
rs1295933020
CA361983423
1232 I>T No ClinGen
gnomAD
TCGA novel 1233 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 1243 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA361983655
rs1561796993
1247 N>S No ClinGen
Ensembl
rs1304050175
CA361983674
1249 Y>H No ClinGen
gnomAD
CA130183461
rs987772341
1250 M>V No ClinGen
TOPMed
gnomAD
rs759023322
CA3534425
1251 K>M No ClinGen
ExAC
gnomAD
rs1162322780
CA361983698
1252 S>A No ClinGen
TOPMed
rs766552634
CA130183483
1253 V>M No ClinGen
TOPMed
rs1356256314
CA361983720
1255 T>I No ClinGen
gnomAD
CA3534428
rs760318555
1256 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs182717318
CA130183488
1256 D>G No ClinGen
1000Genomes
rs370184404
CA3534429
1258 S>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370184404
CA130183497
1258 S>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3534430
rs753609617
1259 T>A No ClinGen
ExAC
gnomAD
rs952468007
CA130183502
1262 H>D No ClinGen
TOPMed
rs765181549
CA3534432
1262 H>R No ClinGen
ExAC
gnomAD
rs371399881
CA3534433
1264 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3534434
rs201882855
1264 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA130183518
rs754090399
1268 P>T No ClinGen
Ensembl
rs778186111
CA3534438
1272 Q>R No ClinGen
ExAC
gnomAD
CA361983842
rs1366154620
1274 L>F No ClinGen
gnomAD
rs749612146
CA3534439
1277 T>N No ClinGen
ExAC
rs1440870902 1279 C>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA

1 associated diseases with Q96F07

[MIM: 618008]: Developmental and epileptic encephalopathy 65 (DEE65)

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE65 is an autosomal dominant form characterized by onset of intractable seizures usually in the first 6 months of life and severe to profound psychomotor developmental delay. {ECO:0000269|PubMed:29534297}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE65 is an autosomal dominant form characterized by onset of intractable seizures usually in the first 6 months of life and severe to profound psychomotor developmental delay. {ECO:0000269|PubMed:29534297}. Note=The disease is caused by variants affecting the gene represented in this entry.

1 regional properties for Q96F07

Type Name Position InterPro Accession
domain CYRIA/CYRIB, Rac1 binding domain 64 - 274 IPR009828

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Cytoplasm, perinuclear region
  • Synapse, synaptosome
  • Highly expressed in the perinuclear regionand enriched in synaptosomes (By similarity)
  • Treatment with leptomycin-B triggers translocation to the nucleus (PubMed:17245118)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

10 GO annotations of cellular component

Name Definition
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
SCAR complex A pentameric complex that includes orthologues of human PIR121, Nap1, Abi, SCAR, and HSPC300 and regulates actin polymerization and/or depolymerization through small GTPase mediated signal transduction.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

1 GO annotations of molecular function

Name Definition
small GTPase binding Binding to a small monomeric GTPase.

8 GO annotations of biological process

Name Definition
activation of cysteine-type endopeptidase activity Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase.
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
cell morphogenesis The developmental process in which the size or shape of a cell is generated and organized.
cell-cell adhesion The attachment of one cell to another cell via adhesion molecules.
dendrite extension Long distance growth of a single dendrite involved in cellular development.
positive regulation of neurotrophin TRK receptor signaling pathway Any process that activates or increases the frequency, rate or extent of the neurotrophin TRK receptor signaling pathway.
positive regulation of proteolysis Any process that activates or increases the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
regulation of actin filament polymerization Any process that modulates the frequency, rate or extent of the assembly of actin filaments by the addition of actin monomers to a filament.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5SQX6 Cyfip2 Cytoplasmic FMR1-interacting protein 2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MTTHVTLEDA LSNVDLLEEL PLPDQQPCIE PPPSSIMYQA NFDTNFEDRN AFVTGIARYI
70 80 90 100 110 120
EQATVHSSMN EMLEEGHEYA VMLYTWRSCS RAIPQVKCNE QPNRVEIYEK TVEVLEPEVT
130 140 150 160 170 180
KLMKFMYFQR KAIERFCSEV KRLCHAERRK DFVSEAYLLT LGKFINMFAV LDELKNMKCS
190 200 210 220 230 240
VKNDHSAYKR AAQFLRKMAD PQSIQESQNL SMFLANHNRI TQCLHQQLEV IPGYEELLAD
250 260 270 280 290 300
IVNICVDYYE NKMYLTPSEK HMLLKVMGFG LYLMDGNVSN IYKLDAKKRI NLSKIDKFFK
310 320 330 340 350 360
QLQVVPLFGD MQIELARYIK TSAHYEENKS KWTCTQSSIS PQYNICEQMV QIRDDHIRFI
370 380 390 400 410 420
SELARYSNSE VVTGSGLDSQ KSDEEYRELF DLALRGLQLL SKWSAHVMEV YSWKLVHPTD
430 440 450 460 470 480
KFCNKDCPGT AEEYERATRY NYTSEEKFAF VEVIAMIKGL QVLMGRMESV FNQAIRNTIY
490 500 510 520 530 540
AALQDFAQVT LREPLRQAVR KKKNVLISVL QAIRKTICDW EGGREPPNDP CLRGEKDPKG
550 560 570 580 590 600
GFDIKVPRRA VGPSSTQACQ WSPRALFHPT GGTQGRRGCR SLLYMVRTML ESLIADKSGS
610 620 630 640 650 660
KKTLRSSLDG PIVLAIEDFH KQSFFFTHLL NISEALQQCC DLSQLWFREF FLELTMGRRI
670 680 690 700 710 720
QFPIEMSMPW ILTDHILETK EPSMMEYVLY PLDLYNDSAY YALTKFKKQF LYDEIEAEVN
730 740 750 760 770 780
LCFDQFVYKL ADQIFAYYKA MAGSVLLDKR FRAECKNYGV IIPYPPSNRY ETLLKQRHVQ
790 800 810 820 830 840
LLGRSIDLNR LITQRISAAM YKSLDQAISR FESEDLTSIV ELEWLLEINR LTHRLLCKHM
850 860 870 880 890 900
TLDSFDAMFR EANHNVSAPY GRITLHVFWE LNFDFLPNYC YNGSTNRFVR TAIPFTQEPQ
910 920 930 940 950 960
RDKPANVQPY YLYGSKPLNI AYSHIYSSYR NFVGPPHFKT ICRLLGYQGI AVVMEELLKI
970 980 990 1000 1010 1020
VKSLLQGTIL QYVKTLIEVM PKICRLPRHE YGSPGILEFF HHQLKDIIEY AELKTDVFQS
1030 1040 1050 1060 1070 1080
LREVGNAILF CLLIEQALSQ EEVCDLLHAA PFQNILPRVY IKEGERLEVR MKRLEAKYAP
1090 1100 1110 1120 1130 1140
LHLVPLIERL GTPQQIAIAR EGDLLTKERL CCGLSMFEVI LTRIRSYLQD PIWRGPPPTN
1150 1160 1170 1180 1190 1200
GVMHVDECVE FHRLWSAMQF VYCIPVGTNE FTAEQCFGDG LNWAGCSIIV LLGQQRRFDL
1210 1220 1230 1240 1250 1260
FDFCYHLLKV QRQDGKDEII KNVPLKKMAD RIRKYQILNN EVFAILNKYM KSVETDSSTV
1270
EHVRCFQPPI HQSLATTC